SCHEMBL4518405

SCHEMBL4518405

Cc1sc2c(c1C)c(O)c(C(=O)O)c(=O)n2C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.36
RECQL P46063 1/20 0.36
TSHR P16473 3/20 0.33
ALDH1A1 P00352 2/20 0.33
ADORA2B P29275 2/20 0.33
GAA P10253 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MAPK1 P28482 2/20 0.33
LMNA P02545 2/20 0.33
BCAT2 O15382 1/20 0.33
HPGD P15428 1/20 0.33
LDHA P00338 1/20 0.33
LDHB P07195 1/20 0.33
USP2 O75604 1/20 0.32
HTT P42858 1/20 0.32
GPR35 Q9HC97 1/20 0.32
ALOX15 P16050 1/20 0.32
CYP2C19 P33261 1/20 0.32
MAPT P10636 1/20 0.31
THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4509027 0.84 ALDH1A1 (0.39) TSHRALDH1A1ADORA2BGAASMN1; SMN2
SCHEMBL4501941 0.82 NOTUM (0.32) ALDH1A1
SCHEMBL4504058 0.78 KMT2A (0.57) POLBALDH1A1LMNAHPGDHTT
SCHEMBL4510951 0.74 FEN1 (0.51) POLBADORA2BLDHALDHB
SCHEMBL4501800 0.71 GFER (0.39) POLBALDH1A1LDHALDHBMAPT
SCHEMBL31384761 0.71 LDHA (0.43) RECQLTSHRALDH1A1GAALMNA
SCHEMBL116163 0.69 BRD4 (0.38) POLBTSHRALDH1A1ADORA2BSMN1; SMN2
SCHEMBL799433 0.67 ADORA2B (0.45) TSHRALDH1A1ADORA2BMAPK1LMNA
SCHEMBL2208814 0.66 ALDH1A1 (0.37) TSHRALDH1A1ADORA2BGAASMN1; SMN2
SCHEMBL5106235 0.65 NOTUM (0.37) POLBGAAMAPK1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7553849-B2 Compounds ACTIVE BIOTECH AB (SE) 2009-06-30 US disclosed
EP-1776369-B1 THIENOPYRIDONE CARBOXAMIDES AND THEIR MEDICAL USE ACTIVE BIOTECH AB (SE) 2007-10-10 EP disclosed
US-20060004038-A1 Novel compounds ACTIVE BIOTECH AB (SE) 2006-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060004038-A1 Novel compounds REL, CLIC4, C5 POLB 3392/4885RECQL 4030/4885TSHR 98/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.